Hundreds of millions of dollars have been spent on improving tissue fixation to medical implants through different coatings and porous materials with limited results. In orthopaedic surgery, growth and proliferation of bone to long term structural implants would be game changing. To date, bone fixation relies on the mechanical interdigitation by bone growth adjacent to and within the geometry of the implant surface. MST has patent pending technology allowing for the stimulation, amplification and proliferation of bone growth directly on the implant surface. We believe that similar results will also hold true for soft tissues such as tendons, ligaments, and muscle.
Clinically, metal or polymeric implants are relatively inert passive devices to play no active role in bone or soft tissue healing. Even “bone friendly” materials do not result in bone or tissue growth directly to the surface of the material. Current implants, in fact, are sometimes deleterious to healing resulting in relatively avascular fibrous encapsulation. Many implants occupy a large volume of space in areas where bone fusion should take place, thus preventing solid bony continuity.
The MST Bioactivity Technology can revolutionize many different segments of the medical market by providing implant surfaces that are biologically active resulting in stimulation of the bone healing process with attraction of bone healing cells to the surface and acceleration of the bone healing cascade, even away from the surface. MST currently is focused on surfaces that may promote and accelerate bone healing to implants, including joint reconstruction, spinal fixation devices, interbody devices, and dental implants.